Dynorphin A and several other opioid peptides produced dose-dependent, naloxone-reversible pain relief when administered directly into rat brains, confirming their role as natural painkillers.
Dose-dependent analgesiaDynorphin A (1-17) produced increasing pain relief at higher doses, fully reversible by the opioid blocker naloxone
What the researchers found
Dynorphin A produced dose-related, naloxone-reversible analgesia via intracerebroventricular injection, confirming its function as an endogenous opioid painkiller acting through kappa receptors.
Why it matters
This study provided key evidence that dynorphin and related opioid peptides are natural painkillers in the brain, advancing understanding of how the body's endogenous opioid system manages pain.
How the study worked
Male Sprague-Dawley rats were surgically implanted with brain ventricle cannulas. After recovery, they received injections of dynorphin A or other opioid peptides, and pain response was measured using a cold-water tail-flick assay at -10°C.
What this study cannot tell us
This was an animal study with direct brain injection, a route not applicable to humans. The cold-water tail-flick test measures a specific type of acute pain that may not represent chronic pain conditions.
How to read the evidence
Preliminary animal study using direct brain injection in rats. Demonstrates a clear mechanism but is far removed from practical human application.
When this study was published
Published in 1988, this is a foundational study in opioid peptide pharmacology.
The bigger picture
Understanding how natural opioid peptides like dynorphin relieve pain has been fundamental to developing targeted pain therapies that might work through specific receptor subtypes with fewer side effects than traditional opioids.
Questions still open
- Could kappa receptor-targeted therapies provide pain relief with fewer addiction risks than traditional opioids?
- How do these findings translate to pain management strategies in humans?
Common questions
What is dynorphin?
What does 'naloxone-reversible' mean?
Read the original research
Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
The Journal of pharmacology and experimental therapeutics, 246(2), 449-53
Citation
Tiseo, P J; Geller, E B; Adler, M W. (1988). Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.. The Journal of pharmacology and experimental therapeutics, 246(2), 449-53.